Keeping Myeloma in Check: The Past, Present and Future of Immunotherapy in Multiple Myeloma

Keeping Myeloma in Check: The Past, Present and Future of Immunotherapy in Multiple Myeloma

Multiple myeloma is an incurable disease of malignant plasma cells and an ideal target for modern immune therapy. The unique plasma cell biology maintained in multiple myeloma, coupled with its hematological nature and unique bone marrow microenvironment, provide an opportunity to design specificall...

Full description

Bibliographic Details
Main Authors: James Ackley, Miguel Armenta Ochoa, Delta Ghoshal, Krishnendu Roy, Sagar Lonial, Lawrence H. Boise
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Cancers
Subjects:
multiple myeloma
immunotherapy
IMiD
antibody
ADC
bi-specific antibody
Online Access:https://www.mdpi.com/2072-6694/13/19/4787

Internet

https://www.mdpi.com/2072-6694/13/19/4787

Similar Items